Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2019-12-01
2020-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Whenever a frontal approach for neurosurgical procedures is required or the frontal placement of the EEG is not indicated, it would not be possible to place the SedLine® .
Numerous studies have analyzed the change of position and the application of alternative positions for other devices used in assessing the depth of anesthesia. Albeit, yet to date, there is no study that analyzed the application of alternative positions for the SedLine® sensor.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EEG Monitoring Under Anaesthesia in Children: Towards Personalized Anaesthesia Care
NCT04103138
Improving Information Extraction From EEG on Cerebral Anesthetic Drug Effects
NCT02043938
Sedline EEG Guided Depth of Anesthesia
NCT05051982
Sedline 4 Channel Electroencephalogram (EEG) Monitoring During Suppression of Unilateral Hemispheric Function (Wada Test
NCT02503878
Effectiveness of the NeuroSENSE for Monitoring the Hypnotic Depth of Anesthesia
NCT02088671
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The hypothesis is that placing the central sensors in the montage approximately 2 cm below the standard recommended placement, across the nasal bridge and then running under the eyes to the normal temporal leads placement would put the entire montage out of the operative field and would still have corresponding values and EEG signals.
The primary outcome measure is to monitor and compare processed electroencephalograph (EEG) values (PSi- Patient State Index, SEFL- Spectral Edge Frequency Left, SEFR- Spectral Edge Frequency Right, SR-Suppression Ratio, EMG-Electromyography, ARTF-Artifact) and EEG waveforms, on both sensors (standard-Forehead and alternative-Nasal)
Other parameters that will be measure are patient demographics (age, sex, surgery, ASA status, weight, height, BMI).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nasal & Frontal sensor position
One group of participants with two modes of measurement. First mode is standard frontal placement of the SedLine® sensor. Second mode is alternative nasal placement of the SedLine® sensor.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients undergoing simple or complex surgery.
* American Society of Anesthesiologists Classification (ASA) score I to III.
Exclusion Criteria
* Emergency cases
* Cognitive/Mentally impaired or unable to provide consent
* Previous neurological problems affecting EEG
* Dementia
* Use of sedative or drugs that can alter EEG readings
* Patients under head and neck surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Masimo Corporation
INDUSTRY
Cleveland Clinic Abu Dhabi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Boris Tufegdzic
Asst Prof Dr Boris Tufegdzic
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Boris Tufegdzic, MD
Role: PRINCIPAL_INVESTIGATOR
Cleveland Clinic Abu Dhabi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cleveland Clinic Abu Dhabi
Abu Dhabi, , United Arab Emirates
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A-2019-028
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.